Key result
Microfluidic devices enable ex vivo coagulation modeling under physiologic hemodynamics for diagnostics and drug testing.
Answers are grounded in this paper and cite their sources.
The study of blood ex vivo can occur in closed or open systems, with or without flow. Microfluidic devices, which constrain fluids to a small (typically submillimeter) scale, facilitate analysis of platelet function, coagulation biology, cellular biorheology, adhesion dynamics, and pharmacology and, as a result, can be an invaluable tool for clinical diagnostics. An experimental session can accommodate hundreds to thousands of unique clotting, or thrombotic, events. Using microfluidics, thrombotic events can be studied on defined surfaces of biopolymers, matrix proteins, and tissue factor, under constant flow rate or constant pressure drop conditions. Distinct shear rates can be generated on a device using a single perfusion pump. Microfluidics facilitated both the determination of intraluminal thrombus permeability and the discovery that platelet contractility can be activated by a sudden decrease in flow. Microfluidic devices are ideal for multicolor imaging of platelets, fibrin, and phosphatidylserine and provide a human blood analog to mouse injury models. Overall, microfluidic advances offer many opportunities for research, drug testing under relevant hemodynamic conditions, and clinical diagnostics.
No takes yet. Share an insight, caveat, or question.
Colace et al. (2013) conducted a review in Coagulation biology. Microfluidic devices was evaluated. Microfluidic devices enable the study of ex vivo coagulation biology under relevant hemodynamic conditions, offering opportunities for research, drug testing, and clinical diagnostics.
Synapse has enriched 10 related papers. Consider them for comparative context: